314 related articles for article (PubMed ID: 18177830)
1. Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women.
Caughey AB; Washington AE; Kuppermann M
Am J Obstet Gynecol; 2008 Mar; 198(3):333.e1-8. PubMed ID: 18177830
[TBL] [Abstract][Full Text] [Related]
2. Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff?
Grobman WA; Dooley SL; Welshman EE; Pergament E; Calhoun EA
Prenat Diagn; 2002 Dec; 22(13):1195-200. PubMed ID: 12478632
[TBL] [Abstract][Full Text] [Related]
3. The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage.
Chan YM; Leung TN; Leung TY; Fung TY; Chan LW; Lau TK
Prenat Diagn; 2006 Sep; 26(9):819-24. PubMed ID: 16832829
[TBL] [Abstract][Full Text] [Related]
4. Miscarriage after invasive prenatal diagnostic procedures: how much risk our pregnant women are willing to take?
Chan YM; Sahota DS; Chan OK; Leung TY; Lau TK
Prenat Diagn; 2009 Sep; 29(9):870-4. PubMed ID: 19499531
[TBL] [Abstract][Full Text] [Related]
5. Down Syndrome: what do pregnant women know about their individual risk? A prospective trial.
Strauss A; Heer IM; Spelsberg F; Strauss C
Arch Gynecol Obstet; 2013 Jun; 287(6):1119-23. PubMed ID: 23334105
[TBL] [Abstract][Full Text] [Related]
6. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences.
Kuppermann M; Nease RF; Learman LA; Gates E; Blumberg B; Washington AE
Obstet Gynecol; 2000 Oct; 96(4):511-6. PubMed ID: 11004350
[TBL] [Abstract][Full Text] [Related]
7. Assessment of demand for prenatal diagnostic testing using willingness to pay.
Caughey AB; Washington AE; Gildengorin V; Kuppermann M
Obstet Gynecol; 2004 Mar; 103(3):539-45. PubMed ID: 14990419
[TBL] [Abstract][Full Text] [Related]
8. Do women prefer to have screening tests for Down syndrome that have the lowest screen-positive rate or the highest detection rate?
Mulvey S; Zachariah R; McIlwaine K; Wallace EM
Prenat Diagn; 2003 Oct; 23(10):828-32. PubMed ID: 14558028
[TBL] [Abstract][Full Text] [Related]
9. Do women know that prenatal testing detects fetuses with Down syndrome?
Jaques AM; Halliday JL; Bell RJ
J Obstet Gynaecol; 2004 Sep; 24(6):647-51. PubMed ID: 16147604
[TBL] [Abstract][Full Text] [Related]
10. Reporting Down syndrome screening results: women's understanding of risk.
Nagle C; Hodges R; Wolfe R; Wallace EM
Prenat Diagn; 2009 Mar; 29(3):234-9. PubMed ID: 19177342
[TBL] [Abstract][Full Text] [Related]
11. Women's and health professionals' preferences for prenatal testing for Down syndrome in Australia.
Lewis SM; Cullinane FM; Carlin JB; Halliday JL
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):205-11. PubMed ID: 16704474
[TBL] [Abstract][Full Text] [Related]
12. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice.
Rowe HJ; Fisher JR; Quinlivan JA
Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859
[TBL] [Abstract][Full Text] [Related]
13. History of miscarriage and increased incidence of fetal aneuploidy in subsequent pregnancy.
Bianco K; Caughey AB; Shaffer BL; Davis R; Norton ME
Obstet Gynecol; 2006 May; 107(5):1098-102. PubMed ID: 16648416
[TBL] [Abstract][Full Text] [Related]
14. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
[TBL] [Abstract][Full Text] [Related]
15. Applying decision analysis to facilitate informed decision making about prenatal diagnosis for Down syndrome: a randomised controlled trial.
Bekker HL; Hewison J; Thornton JG
Prenat Diagn; 2004 Apr; 24(4):265-75. PubMed ID: 15065100
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of fragile X relatives with different attitudes toward terminating an affected pregnancy.
Meryash DL
Am J Ment Retard; 1992 Mar; 96(5):528-35. PubMed ID: 1562310
[TBL] [Abstract][Full Text] [Related]
17. Mapping uptake of prenatal diagnosis for Down syndrome and other chromosome abnormalities across Victoria, Australia.
Muggli EE; Collins VR; Halliday JL
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):492-500. PubMed ID: 17116053
[TBL] [Abstract][Full Text] [Related]
18. Intimate partner violence and unwanted pregnancy, miscarriage, induced abortion, and stillbirth among a national sample of Bangladeshi women.
Silverman JG; Gupta J; Decker MR; Kapur N; Raj A
BJOG; 2007 Oct; 114(10):1246-52. PubMed ID: 17877676
[TBL] [Abstract][Full Text] [Related]
19. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
[TBL] [Abstract][Full Text] [Related]
20. Understanding pregnant women's decision making concerning prenatal screening.
van den Berg M; Timmermans DR; Knol DL; van Eijk JT; de Smit DJ; van Vugt JM; van der Wal G
Health Psychol; 2008 Jul; 27(4):430-7. PubMed ID: 18643000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
